Long-term safety and effectiveness of canakinumab in CAPS: results from the β-Confident Registry
Kuemmerle-Deschner JB, Ramos E, Engel K, et al.
RMD Open · 2021
Key Findings
- ●Real-world registry
- ●6-year safety and effectiveness data
Referenced in (1 disease)
Validation history
Full log →- passsource metadataJun 1, 2026, 01:59 PMby pubmed-api
PMID/DOI resolved and recorded from PubMed E-utilities during SEO DOI backfill.
tools: pubmed.esummary
ID: pmid-34001647DOI: 10.1136/rmdopen-2021-001663PMID: 34001647